167 related articles for article (PubMed ID: 18084652)
1. Metabolic transformations of antitumor imidazoacridinone, C-1311, with microsomal fractions of rat and human liver.
Wiśniewska A; Chrapkowska A; Kot-Wasik A; Konopa J; Mazerska Z
Acta Biochim Pol; 2007; 54(4):831-8. PubMed ID: 18084652
[TBL] [Abstract][Full Text] [Related]
2. Similarity between enzymatic and electrochemical oxidation of 2-hydroxyacridinone, the reference compound of antitumor imidazoacridinones.
Mazerska Z
Acta Biochim Pol; 2003; 50(2):515-25. PubMed ID: 12833176
[TBL] [Abstract][Full Text] [Related]
3. In vivo metabolism of the antitumor imidazoacridinone C1311 in the mouse and in vitro comparison with humans.
Calabrese CR; Loadman PM; Lim LS; Bibby MC; Double JA; Brown JE; Lamb JH
Drug Metab Dispos; 1999 Feb; 27(2):240-5. PubMed ID: 9929509
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
5. Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells.
Fedejko-Kap B; Niemira M; Radominska-Pandya A; Mazerska Z
Xenobiotica; 2011 Dec; 41(12):1044-55. PubMed ID: 21859392
[TBL] [Abstract][Full Text] [Related]
6. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
Aprile S; Del Grosso E; Tron GC; Grosa G
Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
[TBL] [Abstract][Full Text] [Related]
7. The imidazoacridinone antitumor drug, C-1311, is metabolized by flavin monooxygenases but not by cytochrome P450s.
Potega A; Dabrowska E; Niemira M; Kot-Wasik A; Ronseaux S; Henderson CJ; Wolf CR; Mazerska Z
Drug Metab Dispos; 2011 Aug; 39(8):1423-32. PubMed ID: 21555506
[TBL] [Abstract][Full Text] [Related]
8. Selective metabolism of E-3,4-bis(4-ethylphenyl)hex-3-ene in rat liver microsomes.
Fabian EJ; Metzler M
Arch Toxicol; 2006 Jan; 80(1):17-26. PubMed ID: 16187102
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.
Tao X; Piao H; Canney DJ; Borenstein MR; Nnane IP
J Pharm Biomed Anal; 2007 Feb; 43(3):1078-85. PubMed ID: 17045772
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.
Liu Z; Huang L; Dai M; Chen D; Wang Y; Tao Y; Yuan Z
Rapid Commun Mass Spectrom; 2008 Apr; 22(7):1009-16. PubMed ID: 18320546
[TBL] [Abstract][Full Text] [Related]
11. Species differences in metabolism of panomifene, an analogue of tamoxifen.
Monostory K; Jemnitz K; Vereczkey L; Czira G
Drug Metab Dispos; 1997 Dec; 25(12):1370-8. PubMed ID: 9394026
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of N-ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450.
Xu L; Krenitsky DM; Seacat AM; Butenhoff JL; Anders MW
Chem Res Toxicol; 2004 Jun; 17(6):767-75. PubMed ID: 15206897
[TBL] [Abstract][Full Text] [Related]
13. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Lang D; Freudenberger C; Weinz C
Drug Metab Dispos; 2009 May; 37(5):1046-55. PubMed ID: 19196846
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of a 14C/3H-labeled GABAA receptor partial agonist in rat, dog and human liver microsomes: evaluation of a dual-radiolabel strategy.
Shaffer CL; Langer CS
J Pharm Biomed Anal; 2007 Mar; 43(4):1195-205. PubMed ID: 17150324
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of the flame retardant tetrabromo-bisphenol A by human and rat sub-cellular liver fractions.
Zalko D; Prouillac C; Riu A; Perdu E; Dolo L; Jouanin I; Canlet C; Debrauwer L; Cravedi JP
Chemosphere; 2006 Jun; 64(2):318-27. PubMed ID: 16473389
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of cyadox in rat, chicken and pig liver microsomes and identification of metabolites by accurate mass measurements using electrospray ionization hybrid ion trap/time-of-flight mass spectrometry.
Liu Z; Huang L; Dai M; Chen D; Tao Y; Wang Y; Yuan Z
Rapid Commun Mass Spectrom; 2009 Jul; 23(13):2026-34. PubMed ID: 19504544
[TBL] [Abstract][Full Text] [Related]
17. In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: a comparison with human liver microsomes.
Quintieri L; Fantin M; Palatini P; De Martin S; Rosato A; Caruso M; Geroni C; Floreani M
Biochem Pharmacol; 2008 Sep; 76(6):784-95. PubMed ID: 18671948
[TBL] [Abstract][Full Text] [Related]
18. 3-ketocholanoic acid is the major in vitro human hepatic microsomal metabolite of lithocholic acid.
Deo AK; Bandiera SM
Drug Metab Dispos; 2009 Sep; 37(9):1938-47. PubMed ID: 19487251
[TBL] [Abstract][Full Text] [Related]
19. [Study on metabolism of tetramethylpyrazine in system of rat liver microsomes].
Kuang XD; Li XH; Xiong YQ
Zhongguo Zhong Yao Za Zhi; 2006 Dec; 31(23):1971-5. PubMed ID: 17348193
[TBL] [Abstract][Full Text] [Related]
20. In-vitro metabolism of the new anxiolytic agent, RWJ-50172, in rat hepatic S9 fraction and microbial transformation in fungi, Cunninghamella sp.
Wu WN; McKown LA; Melton JL; Reitz AB
J Pharm Pharmacol; 2003 Aug; 55(8):1099-105. PubMed ID: 12956899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
